EU watchdog approves Moderna COVID jab for children six to 11

moderna
Credit: Unsplash/CC0 Public Domain

The European Union's drug watchdog Thursday approved Moderna's anti-COVID shot for children aged six to 11, the second vaccine to be approved for younger children in the 27-member bloc.

"The EMA's human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax to include use in aged 6 to 11," the Amsterdam-based European Medicines Agency said in a statement.

The jab, developed by US-based pharmaceutical company Moderna, has already been approved for adults and children aged 12 and above.

"As in the older age group, the vaccine is given as two injections in the muscles of the upper arm, four weeks apart," the EMA said.

Pfizer/BionTech's anti-COVID shot called Comirnaty was greenlit for children aged five to 11 in November.

The regulator has so far approved five vaccines for use in the EU: Pfizer and Moderna, which use messenger RNA technology, AstraZeneca and Johnson & Johnson, which use viral vector technology, and Novavax, which is based on a spike protein produced in a laboratory.


Explore further

EU watchdog backs Pfizer booster for children over 12

© 2022 AFP

Citation: EU watchdog approves Moderna COVID jab for children six to 11 (2022, February 24) retrieved 17 August 2022 from https://medicalxpress.com/news/2022-02-eu-watchdog-moderna-covid-jab.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors